Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $81.29
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have earned an average rating of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on […]
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have earned an average rating of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on […]